Safety of using iodized oil in chemoembolization for liver tumors in patients with previous adverse reactions to iodinated contrast media

Published:February 23, 2009DOI:



      To evaluate the safety of using iodized oil in chemoembolization for liver tumors in patients with previous adverse reactions to iodinated contrast media.

      Materials and methods

      Records were retrospectively reviewed for all patients with a history of an adverse reaction to iodinated contrast media who underwent angiography using gadolinium-based contrast media and/or carbon dioxide at our institution from January 1998 to September 2006. Patients who underwent chemoembolization or hepatic artery infusion for liver tumors using iodized oil were identified.


      There were 84 procedures with use of iodized oil performed in 36 patients. Mild adverse reactions potentially related to iodized oil were seen in two procedures (2.4%). There were no moderate or severe adverse reactions (0.0%).


      Iodized oil can be safely used in patients with previous adverse reactions to iodinated contrast media.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Imaging
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Nakakuma K
        • Tashiro S
        • Hiraoka T
        • Uemura K
        • Konno T
        • Miyauchi Y
        • Yokoyama I
        Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer.
        Cancer. 1983; 52: 2193-2200
        • Takayasu K
        • Shima Y
        • Muramatsu Y
        • Moriyama N
        • Yamada T
        • Makuuchi M
        • Hasegawa H
        • Hirohashi S
        Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents.
        Radiology. 1987; 162: 345-351
        • Sasaki Y
        • Imaoka S
        • Kasugai H
        • Fujita M
        • Kawamoto S
        • Ishiguro S
        • Kojima J
        • Ishikawa O
        • Ohigashi H
        • Furukawa H
        • Koyama H
        • Iwanaga T
        A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge.
        Cancer. 1987; 60: 1194-1203
        • Nakamura H
        • Hashimoto T
        • Oi H
        • Sawada S
        Transcatheter oily chemoembolization of hepatocellular carcinoma.
        Radiology. 1989; 170: 783-786
        • Bhattacharya S
        • Novell JR
        • Winslet MC
        • Hobbs KE
        Iodized oil in the treatment of hepatocellular carcinoma.
        Br J Surg. 1994; 81: 1563-1571
        • Ramsey DE
        • Kernagis LY
        • Soulen MC
        • Geschwind JF
        Chemoembolization of hepatocellular carcinoma.
        J Vasc Interv Radiol. 2002; 13: S211-S221
        • Katayama H
        • Yamaguchi K
        • Kozuka T
        • Takashima T
        • Seez P
        • Matsuura K
        Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media.
        Radiology. 1990; 175: 621-628
        • Wolf GL
        • Mishkin MM
        • Roux SG
        • Halpern EF
        • Gottlieb J
        • Zimmerman J
        • Gillen J
        • Thellman C
        Comparison of the rates of adverse drug reactions. Ionic contrast agents, ionic agents combined with steroids, and nonionic agents.
        Invest Radiol. 1991; 26: 404-410
        • Barrett BJ
        • Parfrey PS
        • McDonald JR
        • Hefferton DM
        • Reddy ER
        • McManamon PJ
        Nonionic low-osmolarity versus ionic high-osmolarity contrast material for intravenous use in patients perceived to be at high risk: randomized trial.
        Radiology. 1992; 183: 105-110
        • Bettmann MA
        • Heeren T
        • Greenfield A
        • Goudey C
        Adverse events with radiographic contrast agents: results of the SCVIR Contrast Agent Registry.
        Radiology. 1997; 203: 611-620
        • Spinosa DJ
        • Kaufmann JA
        • Hartwell GD
        Gadolinium chelates in angiography and interventional radiology: a useful alternative to iodinated contrast media for angiography.
        Radiology. 2002; 223: 319-325
        • Remy-Jardin M
        • Dequiedt P
        • Ertzbischoff O
        • Tillie-Leblond I
        • Bruzzi J
        • Duhamel A
        • Remy J
        Safety and effectiveness of gadolinium-enhanced multi-detector row spiral CT angiography of the chest: preliminary results in 37 patients with contraindications to iodinated contrast agents.
        Radiology. 2005; 235: 819-826
        • Safriel Y
        • Ali M
        • Hayt M
        • Ang R
        Gadolinium use in spine procedures for patients with allergy to iodinated contrast—experience of 127 procedures.
        AJNR Am J Neuroradiol. 2006; 27: 1194-1197
        • Brown DB
        • Cardella JF
        • Sacks D
        • Goldberg SN
        • Gervais DA
        • Rajan D
        • Vedantham S
        • Miller DL
        • Brountzos EN
        • Grassi CJ
        • Towbin RB
        Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy.
        J Vasc Interv Radiol. 2006; 17: 225-232
        • Gunji T
        • Kawauchi N
        • Ohnishi S
        • Ishikawa T
        • Nakagama H
        • Kaneko T
        • Moriyama T
        • Matsuhashi N
        • Yazaki Y
        • Imawari M
        Treatment of hepatocellular carcinoma associated with advanced cirrhosis by transcatheter arterial chemoembolization using autologous blood clot: a preliminary report.
        Hepatology. 1992; 15: 252-257
        • Llovet JM
        • Burroughs A
        • Bruix J
        Hepatocellular carcinoma.
        Lancet. 2003; 362: 1907-1917
        • Camma C
        • Schepis F
        • Orlando A
        • Albanese M
        • Shahied L
        • Trevisani F
        • Andreone P
        • Craxi A
        • Cottone M
        Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.
        Radiology. 2002; 224: 47-54
        • Llovet JM
        • Bruix J
        Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival.
        Hepatology. 2003; 37: 429-442